- 专利标题： Bicyclic-fused heteroaryl or aryl compounds
-
申请号： US16996117申请日： 2020-08-18
-
公开(公告)号： US11702424B2公开(公告)日： 2023-07-18
- 发明人: John David Trzupek , Katherine Lin Lee , Mark Edward Bunnage , Seungil Han , David Hepworth , Frank Eldridge Lovering , John Paul Mathias , Nikolaos Papaioannou , Betsy Susan Pierce , Joseph Walter Strohbach , Stephen Wayne Wright , Christoph Wolfgang Zapf , Lori Krim Gavrin , Arthur Lee , David Randolph Anderson , Kevin Joseph Curran , Christoph Martin Dehnhardt , Eddine Saiah , Joel Adam Goldberg , Xiaolun Wang , Horng-Chih Huang , Richard Vargas , Michael Dennis Lowe , Akshay Patny
- 申请人： Pfizer Inc.
- 申请人地址： US NY New York
- 专利权人： Pfizer Inc.
- 当前专利权人： Pfizer Inc.
- 当前专利权人地址： US NY New York
- 主分类号： C07D491/056
- IPC分类号： C07D491/056 ; C07F7/18 ; C07D401/14 ; C07D405/14 ; C07D217/02 ; C07D217/22 ; C07D217/24 ; C07D239/86 ; C07D239/88 ; C07D263/24 ; C07D207/273 ; C07D498/04 ; C07D209/52 ; A61K31/4015 ; A61K31/47 ; A61K31/4709 ; A61K31/4725 ; A61K31/517 ; A61K31/5377 ; C07C69/94 ; A61K31/541 ; A61K45/06 ; C07D207/26 ; C07D215/48 ; C07D401/12 ; C07D403/12 ; C07D405/12 ; C07D407/14 ; C07D413/12 ; C07D417/12 ; C07D487/04 ; A61K31/40 ; C07D207/08 ; C07D207/267
摘要：
Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula Ia,
as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
公开/授权文献
- US20200377511A1 Bicyclic-Fused Heteroaryl or Aryl Compounds 公开/授权日：2020-12-03
信息查询
